Insights into the in vitro biological properties of Australian beach-cast brown seaweed phenolics.

Five Australian seaweed species, , , , , and , thrive along the country's shorelines. Some of these seaweeds have recognized health benefits but have not been fully investigated in terms of their bioactive components and mechanisms of action. We employed ultrasonication with 70% methanol to extract phenolic compounds from these seaweeds and investigated a range of bioactivities for these extracts, including anti-inflammatory activity exploring urease inhibition, nitric oxide scavenging activity, protein denaturation inhibition, and protease inhibition. Anti-diabetic activities were investigated using α-amylase and α-glucosidase inhibition assays. Anti-proliferative and anti-mitotic activities were evaluated using yeast-cell and green-gram models, respectively. Our findings showed that inhibited nitric oxide, urease, and protease activities, with , , and exhibiting substantial inhibition of protein denaturation. displayed inhibitory effects on both α-amylase and α-glucosidase, whereas targeted only the α-glucosidase enzyme, indicating different mechanisms of anti-diabetic activity. In these anti-mitotic assays, exhibited low cell viability and a significant anti-proliferative effect, particularly within 24 h, while demonstrated notable inhibition at 48 h. LC-ESI-QTOF-MS/MS investigation identified 48 phenolic compounds, including 19 phenolic acids, 20 flavonoids, and 9 other polyphenols. The presence of these compounds in extracts correlated with observed biological activities. These results support the potential health benefits of these seaweeds and link this activity to the presence of bioactive phenolics.